Effects of D-4F on vasodilation and vessel wall thickness in hypercholesterolemic LDL receptor-null and LDL receptor/apolipoprotein A-I double-knockout mice on Western diet.
about
HDL apolipoprotein-related peptides in the treatment of atherosclerosis and other inflammatory disordersSphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protectionGenetic deletion of apolipoprotein A-I increases airway hyperresponsiveness, inflammation, and collagen deposition in the lung.In vivo efficacy of HDL-like nanolipid particles containing multivalent peptide mimetics of apolipoprotein A-I.Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice.Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer4F Peptide reduces nascent atherosclerosis and induces natural antibody production in apolipoprotein E-null mice.Association of pro-inflammatory high-density lipoprotein cholesterol with clinical and laboratory variables in sickle cell diseaseD-4F, an apoA-1 mimetic, decreases airway hyperresponsiveness, inflammation, and oxidative stress in a murine model of asthma.Biological properties of apolipoprotein a-I mimetic peptides.Anion exchange HPLC isolation of high-density lipoprotein (HDL) and on-line estimation of proinflammatory HDLD4F alleviates macrophage-derived foam cell apoptosis by inhibiting CD36 expression and ER stress-CHOP pathwayApolipoprotein E promotes β-amyloid trafficking and degradation by modulating microglial cholesterol levels.In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide.Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches.The Mechanism of Proinflammatory HDL Generation in Sickle Cell Disease Is Linked to Cell-Free Hemoglobin via Haptoglobin.Apolipoprotein E mimetic is more effective than apolipoprotein A-I mimetic in reducing lesion formation in older female apo E null mice.Novel biological functions of high-density lipoprotein cholesterolHDL Mimetic Peptide Administration Improves Left Ventricular Filling and Cardiac output in Lipopolysaccharide-Treated RatsVulnerable plaque: from bench to bedside; local pacification versus systemic therapy.Dysfunctional high-density lipoprotein and the potential of apolipoprotein A-1 mimetic peptides to normalize the composition and function of lipoproteinsApolipoprotein A-1 mimetic D-4F enhances isoflurane-induced eNOS signaling and cardioprotection during acute hyperglycemia.The effect of apolipoprotein mimetic peptides in inflammatory disorders other than atherosclerosisInhibition of myeloperoxidase decreases vascular oxidative stress and increases vasodilatation in sickle cell disease miceApolipoprotein A-I mimetic peptide treatment inhibits inflammatory responses and improves survival in septic rats.Multiple indications for anti-inflammatory apolipoprotein mimetic peptides.New roles of HDL in inflammation and hematopoiesis.HDL as a biomarker, potential therapeutic target, and therapyStructure and function of HDL mimetics.Molecules that mimic apolipoprotein A-I: potential agents for treating atherosclerosis.Apolipoprotein A-I and A-I mimetic peptides: a role in atherosclerosisHigh-density lipoprotein in uremic patients: metabolism, impairment, and therapy.The dual nature of HDL: Anti-Inflammatory and pro-Inflammatory.D4F alleviates macrophage-derived foam cell apoptosis by inhibiting the NF-κB-dependent Fas/FasL pathway.High-density lipoprotein mimetics: promises and challenges.25-Hydroxycholesterol impairs endothelial function and vasodilation by uncoupling and inhibiting endothelial nitric oxide synthase.An apoA-I mimetic peptide facilitates off-loading cholesterol from HDL to liver cells through scavenger receptor BI.Apolipoprotein A-I inhibits experimental colitis and colitis-propelled carcinogenesis.The apolipoprotein A-I mimetic peptide, ETC-642, reduces chronic vascular inflammation in the rabbit.Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I.
P2860
Q27691344-D3F0BA23-A5E0-47AC-A557-E7E367400A64Q28235893-2486D3E0-5EC4-41E0-9275-8A651CE7F49EQ34053084-1B0463E9-8CBF-4CE5-85D1-6E593017986FQ34238652-BA0B206C-C18E-4E49-9954-C215C9DD6A31Q34308238-0AF24478-6525-4EEB-982D-768DA541675DQ34359284-049B26FF-7EF4-4680-8269-6D689F1165F7Q34421798-855BA8DD-B638-406C-8CBA-552B9D93970AQ34466198-59656176-748D-4DE3-9E6F-586E155C0B0DQ34560751-D0D7BBF6-F58C-4B9A-BE0C-5C45E24746BCQ34927488-EDA74127-31B1-4F6B-8255-5587F0CB0A23Q35114897-65FC2B4A-D9FB-41D1-AC01-77EB5735862BQ35217041-679F2CDF-B63A-45F7-982A-E3415531E5D4Q35694025-1C11E8EC-4F59-4FB5-988C-471DA96F09FAQ35760064-649BCB6B-E93D-45EB-AA0B-4F462957A133Q35860029-A1941E40-FD4B-46D9-B7AC-41A2E5681DD1Q36157535-33108543-7B16-46D7-9F42-0027643B87E8Q36282246-B70AA220-7497-4CDE-BDAF-3605B6E484ACQ36406480-696B9FDB-8F20-43F5-9B57-C647ED1D0C8BQ36447185-AB4FA897-22E3-4525-A004-9C2203DA3902Q36612448-3D5F4869-F05D-4F5B-9025-E11C81BCAEB9Q36763561-EBA09AF7-3A2D-4E4A-A578-DD99D8F779BCQ37054501-D83A207D-17E8-4B69-90B1-97FE1E17E06BQ37097367-7ABECD78-81AF-4250-9208-0EE65EF0C776Q37222670-57FB6A77-9B19-4FFD-934F-9CD9514CB0E5Q37298363-C48A7ACC-C529-442D-8869-EAB97091D99DQ37308178-F0808601-01FA-4762-BD1E-E77C8914B9DBQ37314961-95A34AF0-6DA6-426D-B925-50C78FF46F98Q37429173-8FD9AAED-D8DA-4612-87E5-E5AA3E6001DEQ37553765-02F0893D-E0E9-4541-AFE5-104B75A50C74Q37671683-47CB2327-4B9E-4919-9BFF-FE776288C31AQ37957869-FEFCA233-DF5D-415F-91B0-3C842A1D3174Q38084913-5B0215DE-10C1-45BA-A582-DBF62F748A9BQ38527356-741DD648-22D8-424B-874F-F110F562EDE1Q38639717-214E280C-47F0-4FF6-8E1F-B2EFCF7249A8Q38650575-C74CC82E-D1EB-477B-B228-237394AA0D95Q39417123-3BF28520-6449-451D-AB6D-7D5EFFD13E14Q39784725-209F2B05-7222-4ADF-A2BB-97E9201D3AE0Q40637243-9E9926F4-28E0-4814-BFA4-70DE7C30949DQ40988695-A7AE4762-1F0C-4847-A277-8D24AAAA6667Q41829964-F4400F21-882E-4740-BA72-184E7FD6EC0C
P2860
Effects of D-4F on vasodilation and vessel wall thickness in hypercholesterolemic LDL receptor-null and LDL receptor/apolipoprotein A-I double-knockout mice on Western diet.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Effects of D-4F on vasodilatio ...... knockout mice on Western diet.
@en
Effects of D-4F on vasodilatio ...... knockout mice on Western diet.
@nl
type
label
Effects of D-4F on vasodilatio ...... knockout mice on Western diet.
@en
Effects of D-4F on vasodilatio ...... knockout mice on Western diet.
@nl
prefLabel
Effects of D-4F on vasodilatio ...... knockout mice on Western diet.
@en
Effects of D-4F on vasodilatio ...... knockout mice on Western diet.
@nl
P2093
P2860
P1433
P1476
Effects of D-4F on vasodilatio ...... knockout mice on Western diet.
@en
P2093
Deron W Jones
Jingli Wang
Jingsong Ou
John C Densmore
Keith T Oldham
Kirkwood A Pritchard
Paul Signorino
Sushma Kaul
P2860
P304
P356
10.1161/01.RES.0000190634.60042.CB
P577
2005-10-13T00:00:00Z